APIMEDS PHARMACEUTICALS US, INC. (APUS) Operating income 2023–2025
APIMEDS PHARMACEUTICALS US, INC. (APUS) annual operating income history from SEC filings — each fiscal year as reported.
-$11.9MFY2025 · since FY2023: -$747,436 → -$11.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.9M | -834.2% |
| FY2024 | -$1.3M | -70.6% |
| FY2023 | -$747,436 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More APUS financial trends
APUS RevenueAPUS Net incomeAPUS Net marginAPUS Gross profitAPUS Gross marginAPUS Operating marginAPUS Operating cash flowAPUS Free cash flowAPUS Capital expendituresAPUS Return on equityAPUS Stock buybacksAPUS Dividends paidAPUS Total assetsAPUS Total liabilitiesAPUS Shareholders’ equityAPUS overview →